Revenue segments as reported by the company.

Clearing and transaction fees

Market data and information services

Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Compensation and benefits  

Technology

Professional fees and outside services

Amortization of purchased intangibles

Depreciation and amortization

Licensing and other fee agreements

Other expenses

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CME Group

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CME Group achieves record-breaking 2022 performance amidst market challenges

CME Group's 2022 performance was exceptional, marked by record volumes, revenue growth, and successful transitions. The company's focus on innovation, strategic positioning in energy and cryptocurrency markets, and pricing adjustments have driven positive outcomes. Challenges in margins and market uncertainties require careful navigation.

CME Group posts record Q1 earnings, eyes growth in SOFR

CME Group delivered a strong performance in Q1 2023, achieving record revenue and profitability driven by growth in interest rate and options trading.
The company's strategic focus on risk management, shareholder value creation, and market competitiveness positions it well for future growth and revenue generation.
While facing challenges in a competitive market environment, CME Group has opportunities to capitalize on the demand for SOFR products and options trading.
Optimism surrounding the company's future growth potential, coupled with effective expense management and revenue diversification, underpin its resilience and strategic outlook.

CME Group excels in Q2 with record revenue and strategic focus

CME Group's Q2 earnings call showcased strong financial performance, driven by growth across asset classes and a focus on customer-centric strategies. The company's emphasis on innovation, regulatory compliance, and market leadership positions it well for future growth.

CME Group reports strong Q3 earnings, eyes growth amid challenges

CME Group's Q3 2023 earnings call highlighted robust financial performance, operational efficiency, and strategic positioning. Despite facing regulatory challenges and cost management concerns, the company remains confident in its offerings and growth prospects. Opportunities for expansion through innovation and capitalizing on market trends were key discussion points.

CME Group achieves record 2023 results amidst global uncertainties

CME Group's record-breaking performance in 2023 underscores its market leadership and financial strength, with revenue growth, margin expansion, and strong product demand driving positive results.
While facing challenges from global uncertainties and market dynamics, the company's strategic focus on innovation, risk management, and efficiency positions it well to capitalize on opportunities in evolving markets.
By introducing new products, expanding partnerships, and navigating changing market conditions adeptly, CME Group demonstrates resilience and adaptability, paving the way for continued growth and success in the financial industry.
Overall, CME Group's strategic initiatives, financial performance, and market positioning reflect a company poised for sustained success, leveraging opportunities and strengths to overcome challenges and drive future growth.

CME Group achieves record earnings in Q1 2024, eyes growth

CME Group delivered a strong performance in Q1 2024, setting records in revenue and earnings.
The company faces challenges in managing expenses amid growth initiatives and competitive dynamics.
However, CME's strengths in market leadership, network infrastructure, and regulatory alignment position it well for future opportunities.
By capitalizing on data services and revenue growth avenues, CME can continue its upward trajectory in the market.

CME Group achieves record Q3 performance amidst regulatory challenges

CME Group's Q3 performance was exceptional, marked by record volumes and financial metrics. Despite challenges in regulatory compliance and competition, the company is well-positioned for growth through strategic opportunities in interest rate products and retail expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cboe Global Markets

Intercontinental Exchange

Nasdaq

Volatility metrics show an increase, with the VIX averaging 17.0 in 3QTD, up from previous quarters, indicating a more volatile market environment. CME Group exhibits the strongest performance in 3Q24TD, suggesting significant upside to transaction revenues, making it a recommended buy. Cboe also shows strong transaction revenue potential due to increased index options and futures volumes, benefiting from the current volatile market.

With Increased Volatility YOY Exchange Volumes Are Up Nicely In Q3 2024 To Date

Investors need to pay close attention to CME Group (CME) stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in CME Group (CME) Stock?

CME Group's stock (NASDAQ: CME) has largely traded sideways since the beginning of the year and has not seen much change as compared to the 17% rise in the S&P 500 over the same period. In sharp contrast, CME Group's peer Intercontinental Exchange (NYSE: ICE) is up 25% YTD.

Why Isn't CME Group Stock Performance Reflecting Its Record Revenues, Improving Margins?

CHICAGO , Aug. 28, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that it will launch two new wheat spread futures contracts on October 14, pending regulatory review.  The CBOT Wheat - Euronext Milling Wheat No.

CME Group to Launch Wheat Spread Futures on October 14

CHICAGO , Aug. 27, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced it will further expand its cryptocurrency derivatives offerings with the introduction of Bitcoin Friday futures (BFF) on September 30, pending regulatory review. Sized at one-fiftieth of one bitcoin, these new weekly futures contracts will be cash-settled to the CME CF Bitcoin Reference Rate New York Variant (BRRNY) at 4:00 p.m.

CME Group to Launch Bitcoin Friday Futures on September 30

Financial platforms like CME Group have benefits from scale and the network effect through increased digitization. CME is demonstrating strong trading volume and revenue growth, coupled with high profitability. Its attractive valuation, robust dividend yield, and market positioning make CME a compelling long-term investment opportunity.

CME Group Has It All - Growth, Dividend Growth, And Value

CHICAGO , Aug. 26, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that registration is now open for the 21st annual CME Group University Trading Challenge, which will be held from Sunday, October 6, 2024 through Thursday, October 31, 2024. Interested students can register no later than 2 p.m.

CME Group Opens Registration for its 21st Annual Global University Trading Challenge

CME (CME) reported earnings 30 days ago. What's next for the stock?

Why Is CME (CME) Up 5.1% Since Last Earnings Report?

Over the past couple of weeks, global markets have experienced significant price volatility due to fears of recession. Things got serious when the nonfarm payroll data for July was released, achieving a significantly lower figure than the one expected.

CME Group Benefits From Market Volatility

Hess

The "cash trap" is caused by investors flocking to high-yield, risk-free assets due to Fed rate hikes. This influx into money market funds could reverse if rates drop. When rates fall, investors may shift from money market funds to high-yield dividend stocks to maintain income. The need for quality picks will grow in this scenario. High-yield, high-quality dividend stocks with strong business models and solid balance sheets could benefit most, offering both income and stability as the market evolves.

Be Aware Of The Cash Trap - 2 Strong Buy High-Yield Gems To Be Prepared

Robinhood

Interactive Brokers

NVIDIA

Block

Five Bitcoin-centric stocks in focus are: NVDA, COIN, SQ, IBKR, HOOD.

Accumulate Bitcoin for Long-Term Gains: 5 Stocks in Focus

Over $3.5 million awarded through CME Group Foundation's Scholarship program to date CHICAGO , Aug. 14, 2024 /PRNewswire/ -- CME Group Foundation today announced that 18 historically underrepresented students majoring in finance, technology and related fields have each been awarded up to $20,000, which is renewable for three years. Since its launch in 2019, this program has awarded over $3.5 million in scholarships to nearly 100 students at 11 partner colleges and universities in the U.S.  "Through our Foundation and other initiatives, CME Group is committed to supporting future leaders in our community by providing financial assistance and career development opportunities," said Terry Duffy, CME Group Chairman and Chief Executive Officer.

CME Group Foundation Awards 2024 Higher Education Scholarships to Historically Underrepresented Students

CHICAGO , Aug. 5, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its Live Cattle options reached all-time record open interest of 410,120 contracts on August 1, 2024, surpassing the previous record of 399,626 on July 31, 2014. "With demand high and supply at lows not seen for more than 60 years, market participants are turning to CME Group Live Cattle options to effectively hedge their price risk," said John Ricci, Managing Director and Global Head of Agriculture, CME Group.

CME Group Live Cattle Options Reaches New Open Interest Record Surpassing 400,000 Contracts

AbbVie

Antero Midstream Partners

The tech rally is losing steam as economic indicators, including rising unemployment and weak manufacturing data, suggest increasing recession risks. Investors are shifting focus from high-growth tech to value stocks, driven by concerns over valuation and a slowing economic outlook. In this uncertain environment, finding quality investments with solid balance sheets and growth potential is key to navigating potential market turbulence.

High-Yield Harvest: 3 Of My Favorite Dividend Stocks For What's Next

Average Daily  Volume up 24% from July 2023 Record July ADV in interest rate, equity index, metals, agricultural and options products Record  July U.S. Treasury futures and options ADV of 6.6 million contracts International ADV grew 2 8% to 7.6 million contracts CHICAGO , Aug. 2, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its July 2024 market statistics set a new July average daily volume (ADV) record of 24.8 million contracts, up 24% from July 2023. The company's interest rate, equity index, metals, agricultural and options products also reached July ADV records, while its deeply liquid U.S. Treasury complex hit a new July volume record of 6.6 million contracts.

CME Group Reports Record July ADV of 24.8 Million Contracts, with Growth in All Asset Classes and Record Interest Rate ADV of Nearly 12 Million Contracts

OI Highs Indicate Growing Interest in Lithium Market as Participants Seek to Manage Risk Over the Long Term Lithium Hydroxide H1 Volumes Already Surpass Total 2023  CHICAGO , Aug. 1, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its Lithium Hydroxide futures and Lithium Carbonate futures contracts reached record open interest on Wednesday, July 31, 2024. Lithium Hydroxide futures open interest rose to 26,802 contracts, exceeding the previous record of 26,627 contracts set on July 30, 2024.

CME Group Lithium Hydroxide and Lithium Carbonate Futures Hit New Open Interest Records

CME Group Inc.'s stock has recently underperformed, falling 8.5% despite its long-term success and status as a key player in the financial sector. The company boasts a wide-moat business with strong financials, including record revenue growth and high margins, driven by diverse futures and options contracts. Despite challenges like increased competition and low volatility, CME Group's solid earnings, attractive dividends, and current undervaluation make it a compelling buy.

Down But Not Out: Why CME Group Remains One Of My Favorite Dividend Stocks

CHICAGO , July 25, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced plans to launch Adjusted Interest Rate S&P 500 (AIR) Total Return (SOFR) futures on August 26, pending regulatory review. AIR Total Return futures on U.S. indices are designed to provide total return exposure with an overnight floating rate built in.

CME Group to Launch Adjusted Interest Rate S&P 500 Total Return (SOFR) Futures on August 26

Revenue of $1.53 billion set a record. Adjusted EPS of $2.56 exceeded estimates.

CME Group Reports Q2 2024 Results

CME Group (CME) Q2 results reflect benefits of record trading volumes.

CME Group (CME) Q2 Earnings Top on Record Trading Volume

CME Group Inc. (NASDAQ:CME ) Q2 2024 Earnings Conference Call July 24, 2024 8:30 PM ET Company Participants Adam Minick - Head of IR Terrence Duffy - Chairman, CEO Lynne Fitzpatrick - CFO Sunil Cutinho - Chief Information Officer Derek Sammann - Senior Managing Director, Global Head of Commodities Kendal Vroman - Chief Transformation Officer Tim McCourt - Senior Managing Director, Global Head of Financial Julie Winkler - CCO Conference Call Participants Patrick Moley - Piper Sandler Benjamin Budish - Barclays Simon Clinch - Redburn Atlantic Dan Fannon - Jefferies Owen Lau - Oppenheimer Chris Allen - Citi Craig Siegenthaler - Bank of America Kyle Voigt - KBW Michael Cyprys - Morgan Stanley Alex Blostein - Goldman Sachs Brian Bedell - Deutsche Bank Ken Worthington - JP Morgan Eli Abboud - Bank of America Operator Welcome to the CME Group Second Quarter 2024 Earnings Call. At this time I would like to inform all participants that your lines have been placed on a listen-only mode until the question-and-answer session of today's conference.

CME Group Inc. (CME) Q2 2024 Earnings Call Transcript

While the top- and bottom-line numbers for CME (CME) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Here's What Key Metrics Tell Us About CME (CME) Q2 Earnings

CME Group (CME) came out with quarterly earnings of $2.56 per share, beating the Zacks Consensus Estimate of $2.51 per share. This compares to earnings of $2.30 per share a year ago.

CME Group (CME) Tops Q2 Earnings and Revenue Estimates

CME Group on Wednesday beat analyst estimates for its second-quarter profit, as the exchange operator notched record trading volumes, with investors rushing to manage risks in the wake of ongoing geopolitical and economic uncertainties.

Exchange operator CME's profit beats estimates on record trading volumes

Record quarterly adjusted net income and earnings per share Highest Q2 average daily volume (ADV) in company history (26 million contracts) Year-over-year growth across every asset class CHICAGO , July 24, 2024 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today reported financial results for the second quarter of 2024. The company reported revenue of $1.5 billion and operating income of $1.0 billion for the second quarter of 2024.

News for CME Group Stock (CME)